Quantcast

Latest pharmaceutical industry Stories

2014-06-27 23:10:35

In May 2014, the FDA released a draft guidance that covers the selection and approval process for proposed names of both prescription and nonprescription human drugs and biologics. FDAnews has teamed with drug-naming expert Dr. Susan Proulx to present a 90-minute webinar that will look closely at the draft guidance and its recommended 4-step process. Falls Church, VA (PRWEB) June 27, 2014 Choosing the Right Drug Name: How to Increase Your Chances for Approval **FDAnews Webinar** July...

2014-06-27 23:06:11

Supply chain software developer Datex Corporation announced new pharmaceutical editions of its award winning warehouse management software for the pharmaceutical, medical device and life sciences industries. Clearwater, FL (PRWEB) June 27, 2014 Supply chain software developer Datex Corporation announced new pharmaceutical editions of its award winning warehouse management software for the pharmaceutical, medical device and life sciences industries. The new pharmaceutical software...

2014-06-27 23:00:25

ResearchMoz.us include new market research report "Generic and innovative drugs market in Central Europe 2014 Comparative analysis, reimbursement policies and development forecasts for 2014-2018" to its huge collection of research reports. Albany, NY (PRWEB) June 28, 2014 Generic and innovative drugs market in Central Europe, comparative analysis, reimbursement policies and development forecasts for 2014-2018 is a comprehensive guide to the market and all its conditions and...

2014-06-27 21:43:11

BMJ-British Medical Journal US regulator has taken 84 sponsors/investigators/institutions to task over 7 years Failure to protect patient safety and poor record keeping were among the most common violations picked up by the US regulator in the running of clinical trials over a period of seven years, reveals a study published online in the Journal of Medical Ethics. The study authors reviewed the content of 84 first warning letters issued by the United States Food and Drug...

2014-06-27 20:21:21

CHAPEL HILL, N.C., June 27, 2014 /PRNewswire/ -- The iPad is quickly supplanting laptops as the principal tool for enhancing Medical Science Liaisons' (MSLs) interactions with thought leaders. Despite this, deploying iPads requires significant planning, resources, and training to make the investment a success. According to recent research by benchmarking firm, Best Practices, LLC, proper planning and training for MSLs on iPad usage is essential for success. While the study found that 92% of...

2014-06-27 16:23:58

TAMPA, Fla., June 27, 2014 /PRNewswire-USNewswire/ -- ISPE has confirmed that Dinesh Thakur, Executive Chairman at Medassure Global Compliance Corporation, will be the opening keynote speaker at the 2014 ISPE Annual Meeting. The event, which takes place 12 - 15 October in Las Vegas, Nev. USA, is the Society's largest and most significant event of the year. More than 1,600 attendees representing all sectors of the pharmaceutical and biopharmaceutical lifecycle are expected. Two hundred...

2014-06-27 12:26:08

Series C Round Financing led by Canaan Partners NEW YORK, June 27, 2014 /PRNewswire/ -- Truveris, a leading platform for pharmacy pricing and benefits analysis, today announced it raised $12.75 million in a Series C Round financing. Canaan Partners led the investment and was joined by existing investors New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round. Truveris will use the funds to scale the firm's sales and marketing teams and further...

2014-06-27 12:25:58

Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure NEW BRUNSWICK, N.J., June 27, 2014 /PRNewswire/ -- Ohm Laboratories, Inc. (Ohm), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis....

2014-06-27 08:25:47

LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ -- Commercial and Operational Alliance to Provide Clinical Trials Industry With Global Capabilities and a Full Range of Therapeutic Areas and Modality Expertise IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today said they have signed an Alliance Framework Agreement and...

2014-06-27 08:24:56

DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9kp9sq/ophthalmic_drugs) has announced the addition of the "2014 Report on the International (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) Ophthalmic Drugs Market - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related